ARTICLE | Financial News

CRISPR stocks add over $530 million in market cap

January 30, 2018 1:46 AM UTC

Another multi-billion dollar biotech takeout and the publication of two papers in Nature journals conspired to lift CRISPR-based stocks on a busy Monday.

CRISPR Therapeutics AG (NASDAQ:CRSP) added $4.94 (13%) to $44.39, Intellia Therapeutics Inc. (NASDAQ:NTLA) gained $2.10 to $26.81 and Editas Medicine Inc. (NASDAQ:EDIT) rose $4.74 (13%) to $40.70. Combined, the gene editing companies gained over $530 million in market cap. ...